NY Is Set to Legalize Recreational Marijuana
March 31, 2021 | Robert C. Kern, Jr. | Benjamin P. Malerba | Cannabis
UPDATE: Governor Andrew Cuomo just signed into law the Marihuana Regulation and Taxation Act. After years of fits and starts, New York has passed legislation to legalize recreational marijuana under the Marihuana Regulation and Taxation Act (S854-A) which Governor Cuomo intends to sign. The legalization aspect of the bills would take effect immediately, while Senate …
Read More
FDA Warns that Topical Pain-Relief Products Containing CBD Violate FD&C Act
March 24, 2021 | Steven Shapiro | Marc S. Ullman | Cannabis | Compliance, Investigations & White Collar
This week, the U.S. Food and Drug Administration (FDA) issued Warning Letters that effectively declare that the presence of cannabidiol (CBD) as an inactive ingredient in topical over-the-counter (OTC) drug products is a  violation of the federal Food, Drug, and Cosmetic Act (FD&C Act). In a news release issued on March 22, 2021 the FDA …
Read More
If You Sell Marijuana in Any Form, Uncle Sam Wants His Cut
March 11, 2021 | Stella Lellos | Cannabis | Tax
More and more states across the country are legalizing the sale of marijuana products for medical and/or recreational purposes, but marijuana remains effectively prohibited under federal law as a Schedule I controlled substance within the meaning of the federal Controlled Substances Act of 1970. There is, however, one important and practical exception to that prohibition: …
Read More
CBD Health Claims Raise FTC’s Hackles (and Prompt Class Action Suits)
| Marc S. Ullman | Cannabis | Compliance, Investigations & White Collar
Near the end of 2020, in mid-December, the Federal Trade Commission (FTC) launched what it referred to as “Operation CBDeceit,” a law enforcement sweep challenging allegedly unproven representations that CBD products could treat diseases and serious medical conditions such as cancer, diabetes, Alzheimer’s disease and more.            At the same time, the FTC announced proposed settlements with …
Read More
In NY, CBD Manufacturers and Distributors Now Must Be Licensed
February 26, 2021 | Robert C. Kern, Jr. | Benjamin P. Malerba | Compliance, Investigations & White Collar | Cannabis
Governor Andrew Cuomo announced that the New York State Department of Health is now accepting applications from businesses seeking licensure to operate as cannabinoid hemp processors, retailers, or distributors. Cannabinoid hemp includes many CBD products currently available for purchase, including tinctures, vaporizations, oils, topicals, pills, capsules and food and beverages. Pursuant to Article 33-B of …
Read More
The Biden Administration’s Expected Criminal Enforcement Stance on Marijuana
February 1, 2021 | Geoffrey R. Kaiser | Cannabis | Compliance, Investigations & White Collar
As a candidate running for the office he now holds, President Biden advocated decriminalizing the use of marijuana, automatically expunging all prior marijuana use convictions, legalizing marijuana for medical purposes and rescheduling marijuana from Schedule I to Schedule II in order to permit scientific research into its effects, while leaving decisions regarding legalization of marijuana for …
Read More
New York State Appears Poised to Legalize Recreational Marijuana
January 26, 2021 | Robert C. Kern, Jr. | Cannabis
On January 6, 2021, Governor Cuomo announced his latest proposal for the legalization of recreational marijuana in New York. The proposal, outlined generally, consists of: The legalization of the recreational use of marijuana by any individual of the age of 21 or older in the State of New York; The creation of a new Office …
Read More
Cuomo to Again Seek Legalization of Recreational Marijuana in NYS
October 21, 2020 | Cannabis
Earlier this week, Axel Bernabe, Assistant Counsel to NY State Governor Andrew Cuomo, indicated that he expected the state budget to once again include provisions legalizing the recreational use of marijuana and permitting the use of CBD (cannabidiol) in food and beverages. Bernabe disclosed the news during an interview with Canopy Growth Corp.’s David Culver …
Read More
The Cannabis Industry Is Risking It All
October 1, 2020 | James P. Lagios | Joshua D. Smith | Corporate | Cannabis | Insurance Coverage
James Lagios, Joshua Smith and Mark Wagner wrote, “The Cannabis Industry Is Risking It All,” for Mealey’s® Emerging Insurance Disputes. The article discusses the obstacles that cannabis-related businesses face when seeking to use insurance coverage to mitigate their operational risks. To read the article, click here.   …
Read More
The Cannabis Industry Is Risking It All
September 21, 2020 | James P. Lagios | Joshua D. Smith | Cannabis | Insurance Coverage
Cannabis-related entities, like other manufacturing and retail businesses, need insurance coverage to insulate themselves from potential operational liabilities. The cannabis industry, however, faces unique obstacles when seeking to cover its risks. This article discusses a number of the most significant issues to consider before entering into the industry. Companies that manufacture and sell products and …
Read More

Get legal updates and news delivered to your inbox